Clinical Trials Browser

OTHER × Advanced Cancer × Erlotinib Hydrochloride × Clear all

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

Phase 1 Completed

Advanced Cancer

NCT00895128 2015-07-13

Study of Erlotinib in Combination With Dasatinib

Phase 1 Completed

Advanced Cancer